Labcorp Holdings (LTS:0JSY) Equivalent Admissions #: 0.00 (As of . 20)


LTS:0JSY Labcorp Holdings Inc LTS:0JSY
81 GF Score
Price $285.29
GF Value $270.22
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Labcorp Holdings Equivalent Admissions #?

Labcorp Holdings LTS:0JSY 81 Equivalent Admissions # is 0.00 as of . 20. GuruFocus rates LTS:0JSY with a GF Score™ of 81/100 and a GF Value™ of $270.22 (Fairly Valued). The stock has 6 warning signs investors should review.

Equivalent Admissions # are a general measure used to indicate combined inpatient and outpatient volumes.

The historical rank and industry rank for Labcorp Holdings's Equivalent Admissions # or its related term are showing as below:

LTS:0JSY's Equivalent Admissions # is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median:
* Ranked among companies with meaningful Equivalent Admissions # only.

Labcorp Holdings Equivalent Admissions # Historical Data

* Premium members only.

The historical data trend for Labcorp Holdings's Equivalent Admissions # can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labcorp Holdings Equivalent Admissions # Chart


LTS:0JSY
81GF Score
Labcorp Holdings Inc LTS:0JSY
Equivalent Admissions # is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions
What does a Equivalent Admissions # of 0.00 mean?
Labcorp Holdings (LTS:0JSY) has a Equivalent Admissions # of 0.00 as of . 20. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Labcorp Holdings and its competitors.
Is Labcorp Holdings' Equivalent Admissions # too high?
Labcorp Holdings' current Equivalent Admissions # is 0.00. Overall, Labcorp Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' Equivalent Admissions # compare to DGX and GH?
Labcorp Holdings' Equivalent Admissions # of 0.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equivalent Admissions # for a Medical Diagnostics & Research company?
A good Equivalent Admissions # depends on the Medical Diagnostics & Research industry context. However, Equivalent Admissions # should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equivalent Admissions # mean?
A high Equivalent Admissions # can signal that a stock is expensive relative to its fundamentals. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Labcorp Holdings and its competitors. Labcorp Holdings's current Equivalent Admissions # is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Fairly Valued. The stock's GF Value™ is $270.22, compared to a current price of $285.29 — trading 5.6% above its estimated fair value. The current Equivalent Admissions # is 0.00. Labcorp Holdings' overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equivalent Admissions # calculated?
Equivalent Admissions # is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current Equivalent Admissions # is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?

Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued. The current stock price of $285.29 is trading 5.6% above its estimated GF Value™ of $270.22. GuruFocus considers Labcorp Holdings to be Fairly Valued.

Key valuation signals for LTS:0JSY:

  • Equivalent Admissions #: 0.00
  • GF Value™: $270.22 vs. price of $285.29 (5.6% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Labcorp Holdings Business Description

Other Exchanges LH:USAN6B:Germany
Address 358 South Main Street, Burlington, NC, USA, 27215
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
81GF Score

Get the complete analysis for LTS:0JSY

Equivalent Admissions # is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$285.29
Price
$270.22
GF Value